A qualitative study on the influencing factors of prescription circulation and its platform construction

GUO Yijiao; LIU Deyang; TANG Xiaorong; HU Ming

doi:10.6039/j.issn.1001-0408.2023.11.05

您当前的位置：

首页 >

文章列表页 >

A qualitative study on the influencing factors of prescription circulation and its platform construction

更新时间：2023-06-09

- A qualitative study on the influencing factors of prescription circulation and its platform construction
- ZHONGGUO YAOFANG Vol. 34, Issue 11, Pages: 1307-1312(2023)
- 作者机构：
  
  1.四川大学华西药学院，成都　610041
  2.四川省药械招标采购服务中心，成都　610095
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.11.05
  CLC： R951
- Published：15 June 2023，
  
  Received：17 October 2022，
  
  Revised：05 May 2023，
扫描看全文
郭一娇,刘德阳,唐晓蓉等.处方流转的影响因素分析及其平台构建的质性研究 ^Δ[J].中国药房,2023,34(11):1307-1312.

GUO Yijiao,LIU Deyang,TANG Xiaorong,et al.A qualitative study on the influencing factors of prescription circulation and its platform construction[J].ZHONGGUO YAOFANG,2023,34(11):1307-1312.
郭一娇,刘德阳,唐晓蓉等.处方流转的影响因素分析及其平台构建的质性研究 ^Δ[J].中国药房,2023,34(11):1307-1312. DOI： 10.6039/j.issn.1001-0408.2023.11.05.

GUO Yijiao,LIU Deyang,TANG Xiaorong,et al.A qualitative study on the influencing factors of prescription circulation and its platform construction[J].ZHONGGUO YAOFANG,2023,34(11):1307-1312. DOI： 10.6039/j.issn.1001-0408.2023.11.05.

摘要

目的

探究“互联网+”处方流转的影响因素以及处方流转平台构建规范，为政府制定相关政策以及处方流转平台规范建设提供参考。

方法

选取四川省医疗机构处方流转过程中的利益相关者进行关键知情人访谈，并使用扎根理论对资料进行分析。

结果

处方流转的影响因素可归结为参与者因素、行政决策因素、信息技术因素三大方面。处方流转的影响因素主要在于药店准入退出机制、医保报销服务、配套政策情况和药学服务能力方面。在药店准入退出机制方面，应考虑药店资质、药学服务人员、药品配备和配送情况等，统一药店准入标准；在医保报销服务方面，应积极对接社会药店，实现定点药店流转处方医保报销；在配套政策方面，应注重构建处方流转顶层设计；在药学服务能力方面，应定期培训和考核药店执业药师用药咨询、处方审核等药学服务能力。

结论

参与者影响处方流转较多，药店准入退出机制和药学服务能力有待提升。处方流转平台建设类型多样，但各具优劣性。建议相关政府部门应提高药店准入门槛、跟进医保报销服务和配套政策、探索提升药学服务能力，主导并出台相关政策及措施，促进处方流转，使“互联网+”处方流转有序发展。

Abstract

OBJECTIVE

To explore the influential factors for “Internet +” prescription circulation and construction specifications of prescription circulation platform， so as to provide reference for the government to formulate relevant policies and standardized construction of prescription circulation platform.

METHODS

Stakeholders in the process of prescription circulation service in medical institutions in Sichuan province were selected to conduct key insider interviews， and grounded theory was used to analyze the data.

RESULTS

The influential factors of prescription circulation could be divided into three aspects： participant factor， administrative decision factor and information technology factor. The influential factors of prescription circulation mainly lay in pharmacy admission and withdrawal mechanism， medical insurance reimbursement service， supporting policies and pharmaceutical care ability. In terms of pharmacy admission and withdrawal mechanism， pharmacy qualification， pharmaceutical service personnel， drug allocation and distribution should be considered to unify pharmacy admission standards； in terms of medical insurance reimbursement service， it should actively connect with social pharmacies to realize the transfer of prescription medical insurance reimbursement from designated pharmacies； in terms of supporting policies， it should pay attention to the construction of the top-level design of prescription circulation； in terms of pharmaceutical care ability， regular training and assessment of licensed pharmacists should be performed in drug consultation， prescription review and other pharmaceutical care.

CONCLUSIONS

Participants have more influence on prescription circulation， and pharmacy admission and withdrawal mechanism and pharmaceutical care ability need to be improved. There are various types of prescription circulation platform construction， but each has its own advantages and disadvantages. It is suggested that relevant government departments should improve the access threshold of pharmacies， follow up medical insurance reimbursement services and supporting policies， and explore ways to improve pharmaceutical care capacity， leading and issuing relevant policies and measures to promote the prescription circulation service and make the “Internet +” prescription circulation develop in an orderly manner.

关键词

处方流转药店准入退出医保报销药学服务

Keywords

pharmacy admission and withdrawalmedical insurance reimbursementphar- maceutical care

references

姜志敏. 处方流转路径探索多模式并行[J]. 中国药店，2021（11）：24-26.

甘肃省人民政府.全国首个省级电子处方信息共享平台在甘肃启用[EB/OL]. [2022-10-01].http：//www.gansu.gov.cn/gsszf/gsyw/201909/1448090.shtmlhttp://www.gansu.gov.cn/gsszf/gsyw/201909/1448090.shtml.

人民网.山西首家市级电子处方信息共享服务平台在晋城启动[EB/OL]. [2022-10-01].http：//sx.people.com.cn/n2/2020/0605/c352662-34066332.htmlhttp://sx.people.com.cn/n2/2020/0605/c352662-34066332.html.

O’REILLY M，PARKER N. ‘Unsatisfactory Saturation’：a critical exploration of the notion of saturated sample sizes in qualitative research[J]. Qual Res，2013，13（2）：190-197.

CASSIE H，DUNCAN E M，GIBB E A，et al. Qualitative study exploring the key determinants of information gathe- ring to inform the management of over-the-counter （OTC） consultations in community pharmacies[J]. BMJ Open，2019，9（8）：e029937.

刘文生. 甘肃启动全国首个省级电子处方信息共享平台[J]. 中国医院院长，2019（20）：28-29.

谈在祥，王梓丞. 我国电子处方流转外配的法律风险及其对策研究[J]. 中国卫生法制，2020，28（2）：25-29，90.

国家药品监督管理局.药品经营质量管理规范[EB/OL]. [2022-10-01]. https：//www.nmpa.gov.cn/directory/web/nmpa/xxgk/fgwj/bmgzh/20160720102601205.htmlhttps://www.nmpa.gov.cn/directory/web/nmpa/xxgk/fgwj/bmgzh/20160720102601205.html.

沈萍，辛婧媛，杨小珍，等. 宁夏互联网医院电子处方使用情况分析[J]. 宁夏医学杂志，2021，43（1）：89-91.

丁涛. 互联网医院线上线下一体化的内涵及实现路径研究[J]. 卫生经济研究，2022，39（2）：29-31.

湖南省卫生健康委员会.关于印发湖南省处方流转与监管工作方案（试行）的通知[EB/OL].（2021-03-15）[2022-10-01]. http：//wjw.hunan.gov.cn/wjw/xxgk/tzgg/202109/t20210908_20541992. htmlhttp://wjw.hunan.gov.cn/wjw/xxgk/tzgg/202109/t20210908_20541992.html.

广东省药学会.互联网医院处方流转平台规范化管理专家共识[J].今日药学，2020，30（11）：721-727.

福州市人民政府.关于印发福州市电子处方流转试点工作方案的通知[EB/OL].（2019-03-08）[2022-10-01]. http：//www.fuzhou.gov.cn/zgfzzt/sybzx/ylbzjj/ybdt/201903/t20190322_2787109.htmhttp://www.fuzhou.gov.cn/zgfzzt/sybzx/ylbzjj/ybdt/201903/t20190322_2787109.htm.

重庆市医疗保障局，重庆市卫生健康委员会，重庆市药品监督管理局.关于做好医保电子处方流转与实时结算有关工作的通知公开征求意见[EB/OL].[2022-10-01].https：//ylbzj.cq.gov.cn/hdjl_535/yjzj/202107/t20210730_9529003.htmlhttps://ylbzj.cq.gov.cn/hdjl_535/yjzj/202107/t20210730_9529003.html.

天津市医疗保障局.关于支持处方流转医保政策的通知[EB/OL].（2021-12-18）[2021-12-20]. https：//ylbz.tj.gov.cn/xwzx/tzgg/202112/t20211220_5755744.htmlhttps://ylbz.tj.gov.cn/xwzx/tzgg/202112/t20211220_5755744.html.

国家医疗保障局，国家卫生健康委.关于建立完善国家医保谈判药品“双通道”管理机制的指导意见[EB/OL].（2021-04-22）[2022-10-01]. http：//www.nhsa.gov.cn/art/2021/5/10/art_53_5028.htmlhttp://www.nhsa.gov.cn/art/2021/5/10/art_53_5028.html.

国家医疗保障局.关于优化医保领域便民服务的意见[EB/OL].（2021-07-16）[2022-10-01]. http：//www.nhsa.gov.cn/art/2021/7/16/art_53_5569.htmlhttp://www.nhsa.gov.cn/art/2021/7/16/art_53_5569.html.

国家医疗保障局.关于积极推进“互联网+”医疗服务医保支付工作的指导意见[EB/OL].（2020-10-24）[2022-10-01]. http：//www.nhsa.gov.cn/art/2020/11/2/art_53_3802.htmlhttp://www.nhsa.gov.cn/art/2020/11/2/art_53_3802.html.

国务院.医疗保障基金使用监督管理条例[EB/OL].（2021-01-15）[2022-10-01]. http：//www.gov.cn/zhengce/content/2021-02/19/content_5587668.htmhttp://www.gov.cn/zhengce/content/2021-02/19/content_5587668.htm.

张晓旭.聚集在海南的互联网医院，现在怎么样了？[EB/OL].[2021-06-09]. https：//mp.weixin.qq.com/s/2YOWcgdnHdjD9tPt6yzOYwhttps://mp.weixin.qq.com/s/2YOWcgdnHdjD9tPt6yzOYw.

海南省卫生健康委.海南省电子处方数据接口规范：试行[EB/OL].[2021-07-21]. https：//max.book118.com/html/2021/0726/6242051- 242003220.shtmhttps://max.book118.com/html/2021/0726/6242051-242003220.shtm.

湖北省卫生健康委员会.湖北省互联网医院药学服务管理办法：试行[EB/OL].（2021-01-13）[2022-10-01]. https：//wjw.hubei.gov.cn/zfxxgk/zc/gfwj/202101/t20210114_3244181.shtmlhttps://wjw.hubei.gov.cn/zfxxgk/zc/gfwj/202101/t20210114_3244181.shtml.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Study on pharmaceutical care model for drug-related problems in elderly patients based on comprehensive medication management review

Exploration of pharmaceutical service model in multidisciplinary diagnosis and treatment of rare diseases in children

Pharmacy construction and management of Yanqing Winter （Paralympic） Olympic Village Polyclinic for 2022 Beijing Winter （Paralympic） Olympic Games based on 4M1E method

Survey analysis of influential factors of medication compliance and adverse drug reactions of home-based patients with severe mental disorders in Jinshan district of Shanghai

Related Author

GONG Hui

LI Chen

SHAN Qing

LIU Wei

CHEN Hong

ZHAO Chuan

ZOU Hui

HUANG Zhuanqing

Related Institution

Dept. of Ophthalmology， the 944th Hospital of PLA

Outpatient Department， Jingzhong Medical District of PLA General Hospital

Cadre Diagnosis and Treatment Department， the Sixth Medical Center of PLA General Hospital

Translational Medicine Center， Department of Medical Innovation and Research， PLA General Hospital

Graduate School of PLA General Hospital

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰